Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2020 | (b) 2021 | (c) 2022 | (d) 2023 | (e) 2024 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 1,436,736 | 1,542,927 | 1,182,208 | 1,224,274 | 1,275,550 | 6,661,695 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | 0 | |||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | |||||
| 4 | Total. Add lines 1 through 3 | 1,436,736 | 1,542,927 | 1,182,208 | 1,224,274 | 1,275,550 | 6,661,695 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 3,838,301 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 2,823,394 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2020 | (b) 2021 | (c) 2022 | (d) 2023 | (e) 2024 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 1,436,736 | 1,542,927 | 1,182,208 | 1,224,274 | 1,275,550 | 6,661,695 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 21,509 | 312 | 325 | 10,402 | 36,544 | 69,092 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 33,093 | 36,102 | 48,181 | 45,072 | 47,166 | 209,614 |
| 11 | Total support. Add lines 7 through 10 | 6,940,401 | |||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2020 | (b) 2021 | (c) 2022 | (d) 2023 | (e) 2024 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2020 | (b) 2021 | (c) 2022 | (d) 2023 | (e) 2024 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2024 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2024 |
(iii) Distributable Amount for 2024 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2024 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2024 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2024: | ||||
| a From 2019....... | ||||
| b From 2020....... | ||||
| c From 2021....... | ||||
| d From 2022....... | ||||
| e From 2023....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2024 distributable amount | ||||
|
i
Carryover from 2019 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2024 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2024 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2024, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2024. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2025. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2020..... | ||||
| b Excess from 2021..... | ||||
| c Excess from 2022..... | ||||
| d Excess from 2023..... | ||||
| e Excess from 2024..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| Schedule A, Part II, Line 10 Other Income | DESCRIPTION - CATERING, COLUMN A - 8843.0, COLUMN B - 27669.0, COLUMN C - 39649.0, COLUMN D - 36337.0, COLUMN E - 39042.0, COLUMN F - 151540.0; DESCRIPTION - ALL OTHER REVENUE, COLUMN A - 24250.0, COLUMN B - 8433.0, COLUMN C - 8532.0, COLUMN D - 8735.0, COLUMN E - 8124.0, COLUMN F - 58074.0; |
| Software ID: | 24020961 |
| Software Version: | 2024v5.1 |
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 4a PROGRAM SERVICE DESCRIPTION (CONTINUED) | 12. NUNNA RS, RYOO JS, OSTROV PB, PATEL S, GODOLIAS P, DAHER Z, PRICE R, CHAPMAN JR, OSKOUIAN RJ. SINGLE-LEVEL CERVICAL DISC REPLACEMENT (CDR) VERSUS ANTERIOR CERVICAL DISCECTOMY AND FUSION (ACDF): A NATIONWIDE MATCHED ANALYSIS OF COMPLICATIONS, 30- AND 90-DAY READMISSION RATES, AND COST. WORLD NEUROSURG X. 2023 OCT 18;21:100242. DOI: 10.1016/J.WNSX.2023.100242. PMID: 38221950; PMCID: PMC10787284. ACCEPTED MANUSCRIPTS -PENDING ONLINE PUBLICATION NOTICE 1. DAVIS, D., GOODMANSON, R., PIERRE, C., LEWIK, G., FRIELER, S., ANDERSON, B., RAO, G., PATEL, N., PATEL, N., JOUPPI, L., DAHER, Z., OSKOUIAN, R., CHAPMAN, J. EVALUATION OF RISK FACTORS FOR POST-OPERATIVE URINARY RETENTION IN THE COMPLEX SPINE SURGERY PATIENT AND DEVELOPMENT OF THE PREDICTIVE "POUR SCORE". JAAOS GLOBAL. ACCEPTED. JULY 2024 SUBMITTED MANUSCRIPTS UNDER REVIEW 1. GODOLIAS, P., PLUEMER, J., CIBURA, C., GERSTMEYER, J., HEEP, H., DUDDA, M., PIERRE, C., SCHILDHAUER, T., OSKOUIAN, R., CHAPMAN, J. DOES PRESERVATION OF THE POSTERIOR LIGAMENT COMPLEX IN ELECTIVE LUMBAR FUSION SURGERY MATTER? EARLY RESULTS FROM A SINGLE-CENTER EXPERIENCE. CUREUS. NOV 1, 2024 2. DAHER, Z., JOUPPI L., ANDERSON, B., PIERRE, C., DAVIS, D., PATEL, N., GERSTMEYER, J., RAO, G., NORVELL, D., CRACCHIOLO, G., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. THE ASSOCIATION OF BONE MINERAL DENSITY WITH DISTAL JUNCTIONAL KYPHOSIS AND DISTAL JUNCTIONAL FAILURE AFTER MULTILEVEL SPINE FUSIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS. WORLD NEUROSURGERY. OCT 2024 3. GODOLIAS, P., PIERRE, C., TATARYN, Z., COSTA, M., PRATT, N., ROBINSON, J., FREYVERT, Y., COOKE, J., GOODMANSON, R., DETORRI, J., AL-AWADI, H., OSKOUIAN, R., CHAPMAN, J., SCHELL, B. MULTIPLE-ROD CONSTRUCTS IN THORACOLUMBAR RECONSTRUCTIVE SPINE SURGERY: BUILDING A NOVEL CLASSIFICATION OF HETEROGENEOUS RODS FOR MULTIPLE ETIOLOGIES (CHROME) SCORING SYSTEM. WORLD NEUROSURGERY X. JULY 2024 4. YILMAZ, E., O'LYNNGER, T., VERMEULEN, S., FISAHN, C., STROT, S., MOISI, M., ISHAK, B., DETORRI, J., PIERRE, C., GERSTMEYER, J., OSKOUIAN, R., CHAPMAN, J. SPINAL NERVE SHEATH TUMORS: CONTRASTING SURGICAL RESECTION AND STEREOTACTIC RADIOSURGERY COHORTS. WORLD NEUROSURGERY X. JULY 2024 5. GERSTMEYER, J; GODOLIAS P; SCHILDHAUER TA; PIERRE, C; PATEL, NEEL; DAVID D; ANDERSON B; ABDUL-JABBAR, A; CHAPMAN J, OSKOUIAN, R STAND-ALONE LATERAL INTERBODY FUSION (LLIF): SURGICAL APPROACH AND COMPLICATIONS AFTER 10 YEARS OF EXPERIENCE 6. GERSTMEYER, J; PIERRE, C; GODOLIAS P; PATEL, NEEL; DAVID D; ANDERSON B; ABDUL-JABBAR, A; SCHILDHAUER TA; CHAPMAN J, OSKOUIAN, R. IN-HOSPITAL MORTALITY IN SPONDYLODISCITIS: RISK FACTORS ASSESSED THROUGH THE NATIONAL INPATIENT SAMPLE ANALYSIS. 7. GERSTMEYER, J; PIERRE, C; GODOLIAS P; PATEL, NEEL; DAVID D; ANDERSON B; ABDUL-JABBAR, A; SCHILDHAUER TA; CHAPMAN J, OSKOUIAN, R. BEYOND THE SPINE: EXPLORING MENTAL HEALTH DISORDERS IN SPONDYLODISCITIS. 8. GERSTMEYER, J; PIERRE, C; GODOLIAS P; PATEL, NEEL; DAVID D; ANDERSON B; ABDUL-JABBAR, A; SCHILDHAUER TA; CHAPMAN J, OSKOUIAN, R. THE CONUNDRUM OF FINDING AN OPTIMAL SPONDYLODISCITIS TREATMENT PATHWAY: HOW DO TREATMENTS AFFECT READMISSION RATES? 9. GERSTMEYER, J; PIERRE, C; GODOLIAS P; PATEL, NEEL; DAVID D; ANDERSON B; ABDUL-JABBAR, A; SCHILDHAUER TA; CHAPMAN J, OSKOUIAN, R. INCIDENCE AND PREDICTORS OF READMISSION FOLLOWING HOSPITALIZATION FOR THORACIC DISC HERNIATION 10. GERSTMEYER, J; PIERRE, C; GODOLIAS P; PATEL, NEEL; DAVID D; ANDERSON B; ABDUL-JABBAR, A; SCHILDHAUER TA; CHAPMAN J, OSKOUIAN, R. LUMBAR CORPECTOMY: A COMPREHENSIVE ANALYSIS UTILIZING THE NATIONWIDE READMISSION DATABASE 11. GERSTMEYER J; PIERRE, C; NORVELL, D; DAVIS, D; GOLD, C; HOGSETT, C; KRAEMER, M; MINISSALE, N; SCHILDHAUER, TA; ABDUL-JABBAR, A; OSKOUIAN, R; CHAPMAN, J. MALNUTRITION IN SPONDYLODISCITIS: AN OVERLOOKED RISK FACTOR 12. GERSTMEYER J; GORBACHEVA, A; PIERRE, C; NORVELL, D; HEFFERNAN, T; TABESH; SCHILDHAUER, TA; ABDUL-JABBAR, A; OSKOUIAN, R; CHAPMAN, J. READMISSION RATES AND HOSPITAL CHARGES: A COMPARATIVE STUDY OF SURGICAL INTERVENTIONS IN DEGENERATIVE SPONDYLOLISTHESIS AND SPINAL CANAL STENOSIS 13. GERSTMEYER J; GORBACHEVA, A; PIERRE, C; DAVIS, D; HEFFERNAN, T; JOUPPI, L; GODOLIAS, P; SCHILDHAUER, T; ABDUL-JABBAR, A; OSKOUIAN, R; CHAPMAN, J. RISE OF BIG DATA IN SPINE SURGERY RESEARCH: A BIBLIOMETRIC ANALYSIS 14. GERSTMEYER J; GORBACHEVA, A; PIERRE, C; DAVIS, D; HEFFERNAN, T; JOUPPI, L; GODOLIAS, P; SCHILDHAUER, T; ABDUL-JABBAR, A; OSKOUIAN, R; CHAPMAN, J. GLOBAL INSIGHTS INTO SPONDYLODISCITIS: A BIBLIOMETRIC ANALYSIS OF FOUR DECADES OF RESEARCH POSTERS/ORAL ABSTRACT PRESENTATIONS 1. GERSTMEYER, J., PIERRE, C., PATEL, N., ANDERSON, B., PIERRE, C., DAVIS, D., GODOLIAS, P., SCHILDHAUER, T., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. RISK FACTORS AND IN-HOSPITAL MORTALITY IN SPONDYLODISCITIS: INSIGHTS FROM A NATIONAL INPATIENT SAMPLE ANALYSIS. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER PRESENTATION; EUROSPINE ANNUAL MEETING, VIENNA, AUSTRIA. OCT 2024. 2. GERSTMEYER, J., DAHER, Z., JOUPPI L., ANDERSON, B., PIERRE, C., DAVIS, D., PATEL, N., RAO, G., NORVELL, D., CRACCHIOLO, G., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. THE ASSOCIATION OF BONE MINERAL DENSITY WITH DISTAL JUNCTIONAL KYPHOSIS AND DISTAL JUNCTIONAL FAILURE AFTER MULTILEVEL SPINE FUSIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER PRESENTATION; EUROSPINE ANNUAL MEETING, VIENNA, AUSTRIA. OCT 2024. 3. GERSTMEYER, J., PIERRE, C., AVANTAGGIO, A., PATEL, N., ANDERSON, B., PIERRE, C., DAVIS, D., GODOLIAS, P., SCHILDHAUER, T., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. THE HIDDEN RISK: CRANIAL HEMORRHAGES FOLLOWING SPINE SURGERY. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER PRESENTATION; EUROSPINE ANNUAL MEETING, VIENNA, AUSTRIA. OCT 2024. 4. GERSTMEYER, J., GOODMANSON, R., DAVIS, D., PIERRE, C., ANDERSON, B., RAO, G., PATEL, N., OSKOUIAN, R., CHAPMAN, J. POSTOPERATIVE URINARY RETENTION (POUR) IN THE SETTING OF COMPLEX SPINE SURGERY - A RISK FACTOR ANALYSIS. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER PRESENTATION; EUROSPINE ANNUAL MEETING, VIENNA, AUSTRIA. OCT 2024. 5. GERSTMEYER, J., VON GLINSKI A, PIERRE C., JOUPPI, L, GODOLIAS P, NORVELL, DC., ABDUL-JABBAR, A., DEEM, SA., SCHILDHAUER, TA., OSKOUIAN, RJ., CHAPMAN, JR. THE PAC (POSTOPERATIVE AIRWAY COMPROMISE) SCORE - FIRST STEPS TO DEVELOP A POST-SURGERY TOOL FOR THE PREDICTION OF UPPER AIRWAY-RELATED COMPLICATIONS FOLLOWING ANTERIOR CERVICAL SPINE SURGERY. SWEDISH NEUROSCIENCE INSTITUTE. ORAL PRESENTATION; EUROSPINE ANNUAL MEETING, VIENNA, AUSTRIA. OCT 2024. 6. GERSTMEYER, J., PIERRE, C., LEWIK, G., RAO, G., HICKS, J., DAVIS, D., ANDERSON, B., PATEL, N., ABDUL-JABBAR, A., CHAPMAN, J., OSKOUIAN, R. A CADAVER STUDY: THE RELATIONSHIP OF VITAL ORGANS OF THE THORACOLUMBAR JUNCTION DURING A FAR LATERAL APPROACH USING A T-12 CORPECTOMY MODEL. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER PRESENTATION; EUROSPINE ANNUAL MEETING, VIENNA, AUSTRIA. OCT 2024. 7. GERSTMEYER, J., PIERRE, C., SEIDEL, C. PLUEMER, J., NORVELL, D., AVANTAGGIO, A., OSKOUIAN, R., CHAPMAN, J. THORACOLUMBAR BURST FRACTURES: RISK FACTORS ASSOCIATED WITH 90-DAY READMISSIONS- A NATIONWIDE READMISSIONS DATABASE STUDY. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER PRESENTATION; EUROSPINE ANNUAL MEETING, VIENNA, AUSTRIA. OCT 2024 8. JOUPPI L., DAHER, Z., ANDERSON, B., PIERRE, C., DAVIS, D., PATEL, N., GERSTMEYER, J., RAO, G., NORVELL, D., CRACCHIOLO, G., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. THE ASSOCIATION OF BONE MINERAL DENSITY WITH DISTAL JUNCTIONAL KYPHOSIS AND DISTAL JUNCTIONAL FAILURE AFTER MULTILEVEL SPINE FUSIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS. SWEDISH NEUROSCIENCE INSTITUTE. ORAL POSTER PRESENTATION; CONGRESS OF NEUROLOGICAL SURGEONS ANNUAL MEETING, HOUSTON, TX. SEPTEMBER 2024. 9. PIERRE, C., GERSTMEYER, J., AVANTAGGIO, A., PATEL, N., ANDERSON, B., PIERRE, C., DAVIS, D., GODOLIAS, P., SCHILDHAUER, T., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. THE HIDDEN RISK: CRANIAL HEMORRHAGES FOLLOWING SPINE SURGERY. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER PRESENTATION; CONGRESS OF NEUROLOGICAL SURGEONS ANNUAL MEETING, HOUSTON, TX. SEPTEMBER 2024. 10. GERSTMEYER, J., PIERRE, C., PATEL, N., ANDERSON, B., PIERRE, C., DAVIS, D., GODOLIAS, P., SCHILDHAUER, T., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. RISK FACTORS AND IN-HOSPITAL MORTALITY IN SPONDYLODISCITIS: INSIGHTS FROM A NATIONAL INPATIENT SAMPLE ANALYSIS. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER PRESENTATION; CONGRESS OF NEUROLOGICAL SURGEONS ANNUAL MEETING, HOUSTON, TX. SEPTEMBER 2024. |
| Form 990, Part III, Line 4a PROGRAM SERVICE DESCRIPTION (CONTINUED) | 11. PIERRE, C., DAHER, Z., JOUPPI L., ANDERSON, B., DAVIS, D., PATEL, N., GERSTMEYER, J., RAO, G., NORVELL, D., CRACCHIOLO, G., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. THE ASSOCIATION OF BONE MINERAL DENSITY WITH DISTAL JUNCTIONAL KYPHOSIS AND DISTAL JUNCTIONAL FAILURE AFTER MULTILEVEL SPINE FUSIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS. SWEDISH NEUROSCIENCE INSTITUTE. ORAL PRESENTATION; WASHINGTON STATE ASSOCIATION OF NEUROLOGICAL SURGEONS ANNUAL MEETING, CLE ELUM. SEPTEMBER 2024. 12. PATEL, N., VON GLINSKI A, PIERRE C., ELIA C, ISHAK B, GODOLIAS P, BLECHER R, DETORRI JR, NORVELL DC, JOUPPI L, GERSTMEYER J, DEEM SA, GOLDEN JB, SCHILDHAUER TA, OSKOUIAN RJ, CHAPMAN JR. THE PAC (POSTOPERATIVE AIRWAY COMPROMISE) SCORE - FIRST STEPS TO DEVELOP A POST-SURGERY TOOL FOR THE PREDICTION OF UPPER AIRWAY-RELATED COMPLICATIONS FOLLOWING ANTERIOR CERVICAL SPINE SURGERY. SWEDISH NEUROSCIENCE INSTITUTE. RAPID FIRE ORAL PRESENTATION; GLOBAL SPINE CONGRESS; BANGKOK, THAILAND. MAY 2024 13. PIERRE, C., SEIDEL, C., PLUEMER, J., LEWIK, G., AVANTAGGIO, A., NORVELL, D., OSKOUIAN, R., CHAPMAN, J. THORACOLUMBAR BURST FRACTURES: RISK FACTORS ASSOCIATED WITH 90-DAY READMISSIONS- A NATIONWIDE READMISSIONS DATABASE STUDY. SWEDISH NEUROSCIENCE INSTITUTE. ORAL PRESENTATION; GLOBAL SPINE SUMMIT, BANGKOK, THAILAND. MAY 2024 14. LEWIK, G., PIERRE, C., RAO, G., HICKS, J., DAVIS, D., ANDERSON, B., PATEL, N., ABDUL-JABBAR, A., CHAPMAN, J., OSKOUIAN, R. A CADAVER STUDY: THE RELATIONSHIP OF VITAL ORGANS OF THE THORACOLUMBAR JUNCTION DURING A FAR LATERAL APPROACH USING A T-12 CORPECTOMY MODEL. SWEDISH NEUROSCIENCE INSTITUTE. ORAL PRESENTATION; GLOBAL SPINE SUMMIT, BANGKOK, THAILAND. MAY 2024 15. LEWIK, G., PIERRE, C., RAO, G., HICKS, J., DAVIS, D., ANDERSON, B., PATEL, N., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J., ADJACENT SEGMENT FAILURE AFTER MULTILEVEL FUSION FOR DEGENERATIVE SPINAL DISORDERS - IS ALIGNMENT THE ONLY REASON? SWEDISH NEUROSCIENCE INSTITUTE. RAPID FIRE ORAL PRESENTATION; GLOBAL SPINE SUMMIT, BANGKOK, THAILAND. MAY 2024 16. GERSTMEYER, J., VON GLINSKI A, PIERRE C., ELIA C, ISHAK B, GODOLIAS P, BLECHER R, DETORRI JR, NORVELL DC, JOUPPI L, GERSTMEYER J, DEEM SA, GOLDEN JB, SCHILDHAUER TA, OSKOUIAN RJ, CHAPMAN JR. THE PAC (POSTOPERATIVE AIRWAY COMPROMISE) SCORE - FIRST STEPS TO DEVELOP A POST-SURGERY TOOL FOR THE PREDICTION OF UPPER AIRWAY-RELATED COMPLICATIONS FOLLOWING ANTERIOR CERVICAL SPINE SURGERY. SWEDISH NEUROSCIENCE INSTITUTE. ORAL PRESENTATION; GLOBUS SPINE FELLOWS PROGRAM MEETING; AUDUBON, PA. MAY 2024. BEST RESEARCH AWARD*. 17. ANDERSON, B., JOUPPI L., DAHER, Z., PIERRE, C., DAVIS, D., PATEL, N., GERSTMEYER, J., RAO, G., NORVELL, D., CRACCHIOLO, G., ABDUL-JABBAR, A., OSKOUIAN, R., CHAPMAN, J. THE ASSOCIATION OF BONE MINERAL DENSITY WITH DISTAL JUNCTIONAL KYPHOSIS AND DISTAL JUNCTIONAL FAILURE AFTER MULTILEVEL SPINE FUSIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS. SWEDISH NEUROSCIENCE INSTITUTE. ORAL PRESENTATION; AO SPINE FELLOWS ANNUAL MEETING, BANFF, CA. MARCH 2024. 18. PIERRE, C., DAVIS D., GOODMANSON, R., LEWIK, G., FRIELER, S., ANDERSON, B., RAO, G., PATEL, N., OSKOUIAN, R., CHAPMAN, J., POSTOPERATIVE URINARY RETENTION (POUR) IN THE SETTING OF COMPLEX SPINE SURGERY- A RISK FACTOR ANALYSIS. SWEDISH NEUROSCIENCE INSTITUTE. ABSTRACT ORAL PRESENTATION - SPINE DEFORMITY SESSION; AANS/CNS SPINE SUMMIT, LAS VEGAS, NV. FEBRUARY 2024. 19. PIERRE, C., SEIDEL, C., PLUEMER, J., LEWIK, G., AVANTAGGIO, A., NORVELL, D., OSKOUIAN, R., CHAPMAN, J. THORACOLUMBAR BURST FRACTURES: RISK FACTORS ASSOCIATED WITH 90-DAY READMISSIONS- A NATIONWIDE READMISSIONS DATABASE STUDY. SWEDISH NEUROSCIENCE INSTITUTE. ELECTRONIC POSTER; AANS/CNS SPINE SUMMIT, LAS VEGAS, NV. FEBRUARY 2024. BEST ABSTRACT AWARD*. |
| Form 990, Part V, Line 15 SECTION 4960 TAX ON PAYMENTS OF MORE THAN $1,000,000 IN REMUNERATION | INDIVIDUALS LISTED AS OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION THAT ARE PAID BY A RELATED ORGANIZATION ARE COMMON LAW EMPLOYEES OF THE RELATED ORGANIZATION. IT IS THE INTENTION OF PROVIDENCE AND THE FILING ORGANIZATION TO MAKE INFORMATION ACCESSIBLE AND TRANSPARENT, REPORTING THOSE EMPLOYEES OF A RELATED ORGANIZATION WHO HAVE OFFICER AND KEY EMPLOYEE RESPONSIBILITIES TO THE FILING ORGANIZATION. THE RELATED ORGANIZATION COMMON LAW EMPLOYEES ARE INCLUDED IN THE RELATED ORGANIZATION'S SECTION 4960 TAX ANALYSIS AND REPORTING. |
| Form 990, Part VI, Line 2 Family/business relationships amongst interested persons | JOE SABEY AND DAVE SABEY - Family relationship |
| Form 990, Part VI, Line 4 Significant changes to organizational documents | THE ORGANIZATION AMENDED AND RESTATED ITS BYLAWS TO ELIMINATE THE FORMER CORPORATE MEMBER, WESTERN HEALTHCONNECT, VESTING ALL GOVERNANCE AUTORITY IN THE BOAD OF DIRECTORS. IT ALSO UPDATED THE GOVERNANCE STRUCTURE, BOARD COMPOSITION AND TERMS, AND OFFICER RESPONSIBILITIES. |
| Form 990, Part VI, Line 6 Classes of members or stockholders | WESTERN HEALTHCONNECT WAS THE SOLE CORPORATE MEMBER OF SEATTLE SCIENCE FOUNDATION UNTIL AUGUST 14, 2024 AT WHICH POINT SEATTLE SCIENCE FOUNDATION HAD NO MEMBERS |
| Form 990, Part VI, Line 7a Members or stockholders electing members of governing body | SEATTLE SCIENCE FOUNDATION HAD A TIERED GOVERNANCE IN WHICH THE CORPORATE MEMBER RESERVED THE RIGHT TO APPOINT THE SEATTLE SCIENCE FOUNDATION'S GOVERNING BOARD. ALL NOMINATIONS THAT CAME FROM THE SEATTLE SCIENCE FOUNDATION BOARD AS NOMINATIONS MUST HAVE BEEN APPROVED BY WESTERN HEALTHCONNECT, AS THE CORPORATE MEMBER. HOWEVER, AS OF AUGUST 14, 2024, SEATTLE SCIENCE FOUNDATION HAS NO MEMBERS. |
| Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders | CLASSES OF PERSONS, DECISIONS REQUIRING APPROVAL & TYPE OF VOTING RIGHTS THE FOLLOWING POWERS RESIDED WITH THE CORPORATE MEMBER UNTIL AUGUST 14, 2024 AT WHICH POINT SEATTLE SCIENCE FOUNDATION HAD NO MEMBERS: 1) TO ADOPT OR CHANGE THE MISSION, PHILOSOPHY, AND VALUES, INCLUDING THE STRATEGIC PLAN AND MISSION STATEMENT. 2) TO AMEND OR REPEAL THE ARTICLES OF INCORPORATION OR BYLAWS. 3) TO APPROVE THE ACQUISITION OF ASSETS, THE INCURRENCE OF INDEBTEDNESS OR THE LEASE, SALE TRANSFER, ASSIGNMENT OR ENCUMBERING OF ASSETS EXCEEDING A SPECIFIED THRESHOLD, OR THE SALE OR TRANSFER OF ANY PROPERTY WHICH MAY HAVE HISTORICAL OR RELIGIOUS SIGNIFICANCE. 4) TO APPROVE THE DISSOLUTION OR LIQUIDATION. 5) TO APPROVE THE ANNUAL OPERATING AND CAPITAL BUDGETS 6) TO APPOINT THE CERTIFIED PUBLIC ACCOUNTANTS. 7) TO APPROVE THE CLOSURE OF ANY INSTITUTION OR MAJOR ENTITY OR WORK OF THE CORPORATION. |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | THE FORM 990 WAS PREPARED BASED ON INFORMATION RECEIVED FROM VARIOUS DEPARTMENTS OF THE ORGANIZATION INCLUDING THE FINANCE TEAM, HUMAN RESOURCES, PAYROLL, COMPLIANCE AND THE GENERAL COUNSEL'S OFFICE. THE ORGANIZATION ENGAGED AN OUTSIDE ACCOUNTING FIRM TO PREPARE THE RETURN. THE RETURN HAS BEEN REVIEWED BY AN OFFICER OF THE ORGANIZATION. A FULL COPY OF THE FORM 990 WAS PROVIDED TO ALL BOARD MEMBERS PRIOR TO FILING WITH THE IRS. |
| Form 990, Part VI, Line 12c Conflict of interest policy | THE SEATTLE SCIENCE FOUNDATION (SSF) MAINTAINS A COMPREHENSIVE CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL MEMBERS OF THE BOARD OF DIRECTORS, OFFICERS, KEY EMPLOYEES, AND ANY INDIVIDUAL ACTING ON BEHALF OF THE ORGANIZATION IN A DECISION-MAKING CAPACITY. ALL SUCH INDIVIDUALS ARE REQUIRED TO DISCLOSE ANNUALLY, IN WRITING, ANY FINANCIAL INTERESTS OR RELATIONSHIPS THAT COULD CREATE AN ACTUAL OR PERCEIVED CONFLICT OF INTEREST. MONITORING AND DETERMINATION PROCESS PRIOR TO ENTERING ANY PROPOSED TRANSACTION OR ARRANGEMENT, SSF'S ACCOUNTING AND MANAGEMENT TEAMS REVIEW ALL VENDOR RELATIONSHIPS AND CONTRACTOR DOCUMENTATION, INCLUDING REQUIRED W-9 FORMS, TO IDENTIFY POTENTIAL CONFLICTS OF INTEREST. THE CHIEF OPERATING OFFICER (COO), CHIEF EXECUTIVE OFFICER (CEO), AND BOARD CHAIRMAN REVIEW ANY IDENTIFIED DISCLOSURES TO DETERMINE WHETHER A POTENTIAL CONFLICT EXISTS. IF THE POTENTIAL CONFLICT INVOLVES EITHER THE COO OR CEO, THE MATTER IS REFERRED TO THE EXECUTIVE COMMITTEE OF THE BOARD FOR INDEPENDENT REVIEW. IF A POSSIBLE CONFLICT IS IDENTIFIED AFTER A TRANSACTION HAS OCCURRED, THE SAME REVIEW PROCESS IS FOLLOWED TO ASSESS THE EXTENT OF THE CONFLICT AND DETERMINE ANY CORRECTIVE ACTIONS. THIS MAY INCLUDE DISCLOSURE TO THE BOARD, VOIDING OR MODIFYING THE TRANSACTION, OR IMPLEMENTING ADDITIONAL OVERSIGHT MEASURES. REVIEW AND RESOLUTION WHEN A POTENTIAL OR ACTUAL CONFLICT IS IDENTIFIED, THE INDIVIDUAL WITH THE CONFLICT MUST DISCLOSE THE NATURE OF THE CONFLICT IN WRITING AND ABSTAIN FROM PARTICIPATING IN ANY DISCUSSIONS, DELIBERATIONS, OR DECISIONS REGARDING THE MATTER. THE BOARD OF DIRECTORS, EXCLUDING THE INTERESTED INDIVIDUAL(S), REVIEWS THE INFORMATION AND DETERMINES WHETHER THE TRANSACTION IS FAIR, REASONABLE, AND IN THE BEST INTEREST OF SSF. THE DETERMINATION OF WHETHER A CONFLICT EXISTS IS MADE AT THE EXECUTIVE COMMITTEE LEVEL OR BY THE FULL BOARD, DEPENDING ON THE NATURE OF THE TRANSACTION AND THE PARTIES INVOLVED. DOCUMENTATION OF THE CONFLICT, DISCLOSURE, DELIBERATION, AND FINAL DECISION IS MAINTAINED IN THE ORGANIZATION'S RECORDS. RESTRICTIONS AND ENFORCEMENT PERSONS WITH AN IDENTIFIED CONFLICT ARE PROHIBITED FROM PARTICIPATING IN DELIBERATIONS OR VOTING ON THE MATTER. THEY MAY, HOWEVER, PROVIDE FACTUAL INFORMATION OR ANSWER QUESTIONS AT THE REQUEST OF THE DISINTERESTED BOARD MEMBERS. SSF'S MANAGEMENT ENSURES THAT ALL DETERMINATIONS AND RESOLUTIONS ARE DOCUMENTED IN THE BOARD OR COMMITTEE MINUTES. ALL EMPLOYEES AND BOARD MEMBERS REAFFIRM COMPLIANCE WITH THIS POLICY ANNUALLY THROUGH THE SIGNED CONFLICT OF INTEREST DISCLOSURE STATEMENT. ANY VIOLATIONS OF THE POLICY ARE ADDRESSED BY THE BOARD AND MAY RESULT IN DISCIPLINARY ACTION, UP TO AND INCLUDING TERMINATION OR REMOVAL FROM THE BOARD. |
| Form 990, Part VI, Line 15b Process to establish compensation of other employees | PROCESS FOR DETERMINING COMPENSATION FOR THE CHIEF OPERATING OFFICER, THE BOARD CONDUCTED A SURVEY OF SIMILAR POSITIONS AND THE EXECUTIVE COMMITTEE APPROVED THEIR COMPENSATION PACKAGE. COMPENSATION FOR OTHER EMPLOYEES IS EVALUATED BY THE CEO & EXECUTIVES WITH INPUT FROM THE CHAIRMAN. STUDIES ARE COMPLETED BY THE CHAIRMAN'S HR DEPARTMENT AS NEEDED FOR COMPARATIVE PURPOSES. FOR BOARD MEMBERS AND OFFICERS EMPLOYED BY RELATED ORGANIZATIONS, THE FOLLOWING PROCESS APPLIES: IT IS PROVIDENCE'S INTENTION TO MAKE FINANCIAL INFORMATION ACCESSIBLE AND TRANSPARENT. ALTHOUGH THE FILING OF FORM 990 PROVIDES INSIGHT INTO HOW PROVIDENCE ACHIEVES ITS MISSION, DELIVERS ITS PROGRAMS AND STEWARDS ITS FINANCES, DECIPHERING THE INFORMATION DIRECTLY FROM FORM 990 CAN BE CHALLENGING. THE FOLLOWING PARAGRAPHS PROVIDE FURTHER INFORMATION ABOUT THE PROCESS WE USE TO DETERMINE COMPENSATION FOR TOP MANAGEMENT, OFFICERS AND KEY EMPLOYEES. PROVIDENCE HAS A SINGLE FIDUCIARY BOARD, WITH RESPONSIBILITY FOR FINANCIAL OVERSIGHT ASSOCIATED WITH FULFILLMENT OF THE PROVIDENCE MISSION, DEVELOPING SYSTEM POLICIES, PROTECTING THE ASSETS ENTRUSTED TO THE ORGANIZATION AND OVERSEEING THE STRATEGIC AND OPERATIONAL AFFAIRS OF PROVIDENCE'S LEGAL ENTITIES. PROVIDENCE ALSO MAINTAINS A NETWORK OF COMMUNITY ENTITY BOARDS WITH RESPONSIBILITY FOR QUALITY OF CARE OVERSIGHT, COMMUNITY RELATIONS, ADVOCACY AND COMMUNITY NEEDS ASSESSMENTS. PROVIDENCE HAS A CONSISTENT COMPENSATION PHILOSOPHY FOR ALL OF ITS SENIOR EXECUTIVES, INCLUDING ALL OFFICERS. SALARIES FOR SENIOR EXECUTIVES ARE REVIEWED AT LEAST ANNUALLY BY THE EXECUTIVE COMPENSATION COMMITTEE, WHICH IS A COMMITTEE OF THE PROVIDENCE BOARD CONSISTING ONLY OF OUTSIDE, INDEPENDENT DIRECTORS. THE COMMITTEE MAKES SURE, AT EACH OF ITS MEETINGS, THAT NO MEMBER OF THE COMMITTEE HAS A CONFLICT OF INTEREST AS TO ANY EXECUTIVE WHOSE COMPENSATION IS REVIEWED BY THE COMMITTEE. THE EXECUTIVE COMPENSATION COMMITTEE RETAINS AN INDEPENDENT CONSULTANT EACH YEAR TO REVIEW SALARIES OF THOSE IN THE MOST SIGNIFICANT LEADERSHIP ROLES IN THE ORGANIZATION. PART OF THE CONSULTANT'S ROLE IS TO REVIEW AN EXTENSIVE ARRAY OF COMPENSATION SURVEYS OF LARGE, NOT-FOR-PROFIT HEALTH CARE SYSTEMS IN THE UNITED STATES. PROVIDENCE IS ONE OF THE LARGER HEALTH SYSTEMS IN THE COUNTRY, AND AS SUCH, THE BOARD BENCHMARKS EXECUTIVE COMPENSATION AGAINST OTHER LARGE, NOT-FOR-PROFIT HEALTH SYSTEMS THAT ARE SUBSTANTIALLY SIMILAR TO PROVIDENCE IN SIZE AND COMPLEXITY (SUCH AS HAVING A SIMILAR AMOUNT OF ANNUAL NET REVENUE). ADDITIONALLY, BECAUSE PROVIDENCE OFTEN LOOKS TO GENERAL INDUSTRY FOR LEADERS IN CERTAIN FUNCTIONAL AREAS, PROVIDENCE ALSO TAKES INTO CONSIDERATION GENERAL INDUSTRY MARKET DATA IN THESE SPECIAL SITUATIONS. BASE SALARIES FOR PROVIDENCE EXECUTIVES ARE GENERALLY TARGETED TO THE "MEDIAN" LEVEL OF THE MARKET DATA (WHERE HALF THE SALARIES IN THE DATA ARE LOWER AND HALF THE SALARIES IN THE DATA ARE HIGHER), AS IDENTIFIED BY THE INDEPENDENT CONSULTANT AND REVIEWED WITH THE EXECUTIVE COMPENSATION COMMITTEE. THE PRESIDENT/CEO UTILIZES THE MARKET INFORMATION PROVIDED BY THE CONSULTANT ALONG WITH FORMAL PERFORMANCE EVALUATIONS, TO DETERMINE SALARY RECOMMENDATIONS FOR OTHER SENIOR EXECUTIVES. THIS PROCESS INCLUDES A RIGOROUS ANALYSIS OF THOSE RECOMMENDATIONS WITH THE EXECUTIVE COMPENSATION COMMITTEE AS A PART OF THE REVIEW AND APPROVAL PROCESS. TOTAL COMPENSATION IS TIED CLOSELY TO PERFORMANCE OF THE ORGANIZATION AND THE INDIVIDUAL. PERFORMANCE INCENTIVES ALLOW EXECUTIVES TO EARN ADDITIONAL COMPENSATION IF THEY HELP LEAD PROVIDENCE IN ACHIEVING SPECIFIC ORGANIZATIONAL GOALS FOR FURTHERING PROVIDENCE'S OPERATING COMMITMENTS AND STRATEGIC OBJECTIVES. THE BOARD OF DIRECTORS CONDUCTS A THOROUGH REVIEW PROCESS TO ENSURE PERFORMANCE INCENTIVES ARE ALIGNED WITH APPROPRIATE MARKET PRACTICES. THE BOARD'S PROCESS FOR SETTING, REVIEWING AND APPROVING EXECUTIVE COMPENSATION FULLY COMPLIES WITH IRS STANDARDS (TO ASSURE THAT ALL COMPENSATION IS CONSIDERED REASONABLE) AND REFLECTS BEST GOVERNANCE PRACTICES IN THE INDUSTRY. THE PROCESS WAS LAST COMPLETED IN JUNE 2025. |
| Form 990, Part VI, Line 19 Required documents available to the public | THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC UPON REQUEST. |
| Software ID: | 24020961 |
| Software Version: | 2024v5.1 |